Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 102 participants.

Also called NCT07599982

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 102 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07599982
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07599982. Allocation not applicable; no masking; primary purpose treatment. Start 2026-05-25 (actual); primary completion 2027-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Acronym
MODIUS
Condition
Type 1 Diabetes (T1D)
Condition
Type 2 Diabetes (T2D)
Intervention (Device)
MODI Algorithm
Lead sponsor
DreaMed Diabetes (class: industry)
Collaborator
Jaeb Center for Health Research (class: other)
Collaborator
Abbott Diabetes Care (class: industry)

Record details

Record id
cardio:ct-nct07599982
Content hash
5c549c946daed353ecb82252afa51a00e69c86411ea03b1e290cfe75dfa1c39e